Document:

EX-10.1

 Exhibit 10.1 
  

 
 November 5, 2013 

Mr. James F. Gero 
 Chairman of the Board of Orthofix
International N.V. 
 3451 Plano Pkwy 
 Lewisville, TX 75056

 Dear Jim: 
 Per our discussions, we understand that you
intend to retire as Chairman of the Board, and as a director, of Orthofix International N.V. (the “Company”), effective as of November 5, 2013. As further discussed, we appreciate that you have agreed to provide the Company
with certain transition assistance by acting as a consultant to the Board between November 5, 2013 and January 2, 2015 (the “Continued Service Period”). This letter agreement between you and the Company serves to
memorialize the terms that you and the Company have agreed regarding your consulting relationship with the Company and certain related matters. Capitalized terms not defined herein shall have the meanings set forth on Exhibit A. 

Consulting Arrangement 
 During the Continued Service
Period, you will make yourself available to provide consulting services to the board of directors of the Company (the “Board”) eight hours per month at such time(s) as mutually agreed by you and the Company, with in each case at
least one week’s notice and subject to your reasonable scheduling availability. Such consulting services shall be provided at such location(s) as mutually agreed by you and the Company (provided that, in any event, you shall not be asked to
travel more than 25 miles from his Texas or Maine residence), and may include providing strategic advice, market analysis, business development, employee mentoring, or other similar activities. You also agree to make yourself available to
participate telephonically, as needed, during portions of up to two meetings of the Board during the Continued Service Period (which appearances shall be counted for purposes of calculating the eight hours of service referenced in the first sentence
of this paragraph). As payment for you providing these services, the Company shall provide you compensation of (i) $5,000 per month during the Continued Service Period (which payment shall be made whether or not the Board avails itself of all
of the services you are agreeing to provide to the Board hereunder) and (ii) $625 per hour for any consulting services you provide at the Company’s request in excess of eight hours in any given month. In addition, provided that you elect
COBRA in a timely manner, the Company will provide you with a monthly cash payment (subject to applicable taxes and less any required withholding) equal to the cost of continuation coverage under the Company’s medical and dental benefit plans
in which you were participating at the time of your retirement as a director, at the level at which you were 

 
participating (e.g., single or family coverage). Any COBRA continuation coverage that you elect to continue after January 2, 2015 shall be fully at your own expense. You shall perform your
consulting services as an independent contractor, and nothing herein shall create any employment relationship between you and the Company or any of its subsidiaries. Jeffrey M. Schumm, the Company’s Chief Administrative Officer and General
Counsel, shall be your point of contact and liason for scheduling, arranging and providing the consulting services described above and for any other matters related to any transitional or ongoing administrative matters between you and the Company.

 Your vesting and exercise periods with respect to your options to acquire common stock of the Company (“Stock Options”) and grants of
restricted common stock of the Company (“Restricted Stock”) shall be as set forth in the applicable grant agreement and/or plan, provided, however, that for the avoidance of doubt, the parties hereto agree that you shall be deemed
to be a “Service Provider” under the Company’s 2012 Long-Term Incentive Plan (and therefore continue to vest in restricted stock grants made to you thereunder) for so long during the Continued Service Period as you are continuing to
provide consulting services to the Board hereunder. 
 Standstill 

You agree that from and after the date of this letter agreement through January 2, 2015 (the “Protective Period”), unless the prior
written consent of the Board has been obtained, neither you nor any entities of which you are the majority equity owner will in any manner, directly or indirectly, (a) effect, seek, offer, or propose (whether publicly or otherwise), or cause or
participate in (except to sell or tender your Company securities in the ordinary course pursuant to any consummated public sale of the Company) or in any way assist any other person to effect, seek, offer, or propose (whether publicly or otherwise)
(i) any acquisition of beneficial ownership of any securities issued by the Company or any assets of the Company or any of the Company’s direct or indirect subsidiaries (other than (A) pursuant to the exercise of your existing Stock
Options or (B) acquisitions not to exceed in the aggregate more than one percent (1%) of the outstanding shares of Company common stock (excluding Company common stock already beneficially owned by you or entities of which you are the
majority equity owner as of the date hereof or exercisable by you pursuant to Stock Options)); (ii) any tender or exchange offer, merger, or other business combination involving the Company; (iii) any recapitalization, restructuring,
liquidation, dissolution, or other extraordinary transaction with respect to the Company or any of its subsidiaries; or (iv) any “solicitation” of “proxies” (as those terms are used in the proxy rules of the Securities and
Exchange Commission) to vote, or refrain from voting, any voting securities issued by the Company or to solicit any consents of the Company’s shareholders; (b) form, join, or in any way participate in a “group” (as defined under
the Securities Exchange Act of 1934) with respect to any securities issued by the Company or otherwise act, alone or in concert with others, to seek to control or influence (except through providing consulting services hereunder) the Company’s
management, the Board, or the Company’s policies; (c) take any action which might require the Company or any of its subsidiaries to make a public announcement regarding any of the types of matters set forth in (a) or (b) above;
or (d) enter into any discussions or arrangements with any third party with respect to any of the foregoing. 

  
 2 

 Non-Competition; Non-Solicitation and Confidentiality 

You also agree that during the Protective Period you shall not, without the prior written consent of the Board (which may be withheld in the Board’s sole
and absolute discretion), anywhere in the Prohibited Area, for your own account or the benefit of any other, engage or participate in or assist or otherwise be connected with a Competing Business. For the avoidance of doubt, you understand that this
paragraph prohibits you from acting for yourself or as an officer, employee, manager, operator, principal, owner, partner, shareholder, advisor, consultant of, or lender to, any individual or other Person that is engaged or participates in or
carries out a Competing Business or is actively planning or preparing to enter into a Competing Business. The parties agree that such prohibition shall not apply to your passive ownership of not more than 5% of a publicly-traded company. 

In addition, during the Protective Period you shall not, without the prior written consent of the Board (which may be withheld in the Board’s sole
discretion), whether for your own account or for the account or benefit of any other Person, throughout the Prohibited Area: 
  

	 	(a)	request, induce or attempt to influence (i) any customer of the Company or its subsidiaries to limit, curtail, cancel or terminate any business it transacts with, or products or services it receives from or sells
to, or (ii) any Person employed by (or otherwise engaged in providing services for or on behalf of) the Company or its subsidiaries to limit, curtail, cancel or terminate any employment, consulting or other service arrangement, with the Company
or its subsidiaries. Such prohibition shall expressly extend to any hiring or enticing away (or any attempt to hire or entice away) any employee or consultant of the Company or its subsidiaries. 

 

	 	(b)	solicit from or sell to any customer any products or services that the Company or any of its subsidiaries provides or is capable of providing to such customer and that are the same as or substantially similar to the
products or services that the Company or any of its subsidiaries, sold or provided while you are or were providing services to the Board. 

  

	 	(c)	contact or solicit any customer for the purpose of discussing (i) services or products that are competitive with and the same or closely similar to those offered by the Company or any of its subsidiaries or
(ii) any present business of the Company or any of its subsidiaries. 

  

	 	(d)	request, induce or attempt to influence any supplier, distributor or other Person with which the Company or any of its subsidiaries has a business relationship or to limit, curtail, cancel or terminate any business it
transacts with the Company or any of its subsidiaries. 

  

	 	(e)	otherwise interfere with the relationship of the Company or any of its subsidiaries with any Person which is, or within the last year was, doing business with, employed by or otherwise engaged in performing services
for, the Company or any of its subsidiaries. 

 During the Protective Period and at all times thereafter, you agree to hold in secrecy for the
Company all Confidential Information that may come into your knowledge, may have come to your attention or may have come into your possession or control while providing services to the Company and/or the Board. Notwithstanding the preceding
sentence, you shall not be required to maintain the confidentiality of any Confidential Information which (a) is or becomes available to the public or others in the industry generally (other than as a result of disclosure or inappropriate use,
or caused, by you in violation of this paragraph) or (b) you are compelled to disclose under any applicable laws, regulations or directives of any government agency, tribunal or authority having

  
 3 

 
jurisdiction in the matter or under subpoena. Except as expressly required in the performance of your duties under this agreement, you agree not to use for your own benefit or disclose (or permit
or cause the disclosure of) to any Person, directly or indirectly, any Confidential Information unless such use or disclosure has been specifically authorized in writing by the Company in advance. During the period during which you are providing
consulting services to the Board hereunder, the Company may provide and grant you access to certain Confidential Information. You recognize that any Confidential Information is of a highly competitive value, will include Confidential Information not
previously provided you and that the Confidential Information could be used to the competitive and financial detriment of the Company or its subsidiaries if misused or disclosed by you. The Company provides access to such Confidential Information
only in exchange for your promises contained herein. 
 Statements and Disclosures 

You agree that you have not made and shall not make, publicly or privately, any critical or negative comments to the media or any significant critical or
negative comments to any other Person regarding the Company or any of its subsidiaries, or of their respective directors, officers, employees or agents, provided that the foregoing shall in no way limit your right to make any public statements or
disclosures you believe, after consultation with counsel, are required by applicable law, or required or appropriate pursuant to applicable federal securities laws. The Company further agrees that it shall not make, and shall use commercially
reasonable efforts to prevent any of its respective officers or directors from making, any critical or negative comments to the media or other persons about you, provided that the foregoing shall in no way limit the Company’s right to make any
public statements or disclosures it believes, after consultation with counsel, are required or appropriate under applicable law, or required or appropriate pursuant to applicable federal securities laws. 

Governing Law and Venue 
 This agreement shall be
construed, interpreted, and governed in accordance with the laws of the State of Texas without regard to any provision of that state’s rules on the conflicts of law that might make applicable the law of a jurisdiction other than that of the
State of Texas. All actions or proceedings arising out of this agreement shall exclusively be heard and determined in state or federal courts in the City of Dallas of the State of Texas having appropriate jurisdiction. The parties expressly consent
to the exclusive jurisdiction of such courts in any such action or proceeding and waive any objection to venue laid therein or any claim for forum nonconveniens. 

Entire Agreement 
 This Agreement represents the entire
agreement of the parties with respect to the subject matter hereof and shall supersede any and all previous contracts, arrangements or understandings between you and the Company relating to your potentially providing consulting services to the
Company and/or the Board. Nothing in this Agreement shall modify that certain indemnity agreement between you and the Company dated October 31, 2008 (the “Indemnity Agreement”) or, except as specifically set forth herein, alter
any of your rights under the Company’s employee benefit plans or related award agreements, or under the Company’s articles of association, as amended (the “Articles”). In furtherance of the foregoing, the Company reaffirms
its obligations to you under the 

  
 4 

 
Indemnity Agreement and the Articles, including with respect to indemnification and the advancement and/or reimbursement of reasonable legal expenses in certain circumstances on the terms
provided for therein), and agrees that you shall be deemed to be acting in an “official capacity” as defined thereunder while providing the consulting services contemplated by this Agreement. In the event of any conflict between this
agreement and any other agreement between you and the Company, this agreement shall control. 
 [remainder of page intentionally left blank]

 . 

  
 5 

 Please indicate your agreement and acknowledgment to the above by signing where indicated below and returning a
copy to me. Your signature below will also constitute resignation by you, as of the open of business on November 5, 2013, from all officer and director positions with the Company or any of its subsidiaries (including as a director of the
Company). 
  

	
	 Sincerely,

	
	 ORTHOFIX INTERNATIONAL N.V.

	
	 /s/ Bradley R. Mason

	 Bradley R. Mason

	 President and Chief Executive Officer

  

	
	 Agreed and Accepted:

	
	 /s/ James F. Gero

	 James F. Gero

 . 

  
 6 

 Exhibit A 

“Competing Business” means any business or activity that (i) competes with the Company or any of its
subsidiaries and involves (ii) (A) the same or substantially similar types of products or services (individually or collectively) manufactured, marketed or sold by the Company or any of its subsidiaries as of the date hereof or
(B) products or services so similar in nature to that of the Company or any of its subsidiaries as of the date hereof (or that the Company or any of its subsidiaries will soon thereafter offer and are known to Mr. Gero) that they would be
reasonably likely to displace substantial business opportunities or customers of the Company or any of its subsidiaries. 

“Confidential Information” shall include Trade Secrets and includes information acquired by you in the course and
scope of your activities under this agreement or from previously serving as Chairman of the Board or a director of the Company, including information acquired from third parties, that (i) is not generally known or disseminated outside the
Company and its subsidiaries (such as non-public information), (ii) is designated or marked by the Company or any of its subsidiaries as “confidential” or reasonably should be considered confidential or proprietary, or (iii) the
Company or any of its subsidiaries indicates through its policies, procedures, or other instructions, in each case to the extent known to Mr. Gero, should not be disclosed to anyone outside the Company and its subsidiaries. Without limiting the
foregoing definitions, some examples of Confidential Information under this agreement include (a) matters of a technical nature, such as scientific, trade or engineering secrets, “know-how”, formulae, secret processes, inventions, and
research and development plans or projects regarding existing and prospective customers and products or services, and (b) information about costs, profits, markets, sales, customer lists, customer needs, customer preferences and customer
purchasing histories, supplier lists, internal financial data, personnel evaluations, non-public information about the Company’s medical devices or products of the Company or any of its subsidiaries (including future plans about them),
information and material provided by third parties in confidence and/or with nondisclosure restrictions, computer access passwords, and internal market studies or surveys. 

“Person” shall include individuals or entities such as corporations, partnerships, companies, firms, business
organizations or enterprises, and governmental or quasi-governmental bodies. 
 “Prohibited Area” means North
America, South America and the European Union, which Prohibited Area the parties have agreed to as a result of the fact that those are the geographic areas in which the Company and its subsidiaries conduct a preponderance of their business and in
which you provide substantive services to the benefit of the Company and its subsidiaries. 
 “Trade
Secrets” are information of special value, not generally known to the public that the Company or any of its subsidiaries has taken steps to maintain as secret from Persons other than those selected by the Company or any of its
subsidiaries.EX-10.1

 Exhibit 10.1 

Execution Version 

NONDISCLOSURE AND STANDSTILL AGREEMENT 

This Nondisclosure and Standstill Agreement (this “Agreement”) by and between RigNet, Inc., a Delaware corporation
(“RigNet” or the “Company”), and Digital Oilfield Investments LP (formerly known as, Dynamo Investment Partners L.P.) (“Digital”, and together with RigNet, each a “Party” and
collectively, the “Parties”), is dated as of the date set forth on the signature page hereto. 
 1. General. In
connection with Digital’s investment in RigNet (the “Investment”) involving RigNet and/or its subsidiaries (collectively, the “Provider”), the Provider may from time to time make available to Digital and/or its
subsidiaries and affiliates, including private equity or other funds they manage or control (collectively, the “Recipient”), certain “Evaluation Material” (as defined in Section 2 below) in accordance with the
provisions of this Agreement. 
 2. Definitions. 

(a) The term “Evaluation Material” means information concerning the Provider or its business, financial condition, operations,
assets or liabilities, whether disclosed orally or disclosed or accessed in written, electronic or other form or media, whether or not marked, designated or otherwise identified as “confidential,” and whether provided by Provider or any of
its Representatives. Evaluation Material includes, without limitation, (i) design, technical, customer, product, service, financial and/or business information or concepts in written, graphic, oral or other tangible or intangible forms
including, without limitation, drawings, schematics, know-how, notes, models, financial reports and projections, reports, research, contracts, mock-ups, release schedules, samples, specifications, product features, records, data and computer
programs, (ii) any confidential information about or received from a third party that the Company is obligated to keep confidential, which is included with, or incorporated in, any information provided by the Provider to the recipient or its
Representatives, and (iii) all notes, analyses, compilations, reports, forecasts, studies, samples, data, statistics, summaries, interpretations or other materials prepared by or for the Recipient or its Representatives that contain, are based
on, or otherwise reflect or are derived from, in whole or in part, any Evaluation Material. The term Evaluation Material does not include information which (i) is generally available to the public other than as a result of a disclosure by the
Recipient or its Representatives in breach of this Agreement, (ii) was within the Recipient’s possession prior to its being furnished to the Recipient by or on behalf of the Provider, provided that the source of such information was not
known by Recipient or its Representatives to be bound by a confidentiality agreement with, or other contractual, legal or fiduciary obligation of confidentiality to, the Provider with respect to such information, (iii) is or becomes available
to the Recipient on a non-confidential basis from a source other than the Provider or its Representatives, provided that such source is not known by Recipient or its Representatives to be bound by a confidentiality agreement with, or other
contractual, legal or fiduciary obligation of confidentiality to, the Provider with respect to such information, or (iv) has been or becomes independently developed by employees of Recipient who have not had any access to the Evaluation
Material. 

 (b) The term “Representatives” shall include the directors, officers, employees,
agents, partners, members or advisors (including, without limitation, attorneys, accountants, consultants, bankers and financial advisors) of the Recipient or Provider, as applicable. 

(c) The term “Person” includes the media and any corporation, partnership, group, individual or other entity. 

3. Use of Evaluation Material. The Recipient shall, and it shall cause its Representatives to, use the Evaluation Material solely for
the purpose of evaluating the Investment and keep the Evaluation Material confidential in accordance with the terms hereof. Subject to Section 4, Recipient will not, and will cause its Representatives not to, disclose any of the Evaluation
Material in any manner whatsoever; provided, however, that any of such information may be disclosed to the Recipient’s Representatives who need to know such information for the sole purpose of helping the Recipient evaluate the
Investment; and provided further that none of such information may be disclosed directly or indirectly to another private equity firm or other financing source without the Provider’s prior written consent. The Recipient agrees to be
responsible for any breach of this Agreement by any of the Recipient’s Representatives; provided, however, that Recipient will not be responsible for any such breach by any of its Representatives who is not one of its partners,
members, directors, officers or employees who has agreed in a written agreement with RigNet to be bound by the confidentiality provisions of this Agreement. This Agreement does not grant the Recipient or any of its Representatives any intellectual
property rights in, or license to use, the Evaluation Material except as provided herein. All Evaluation Material shall be and remain the exclusive property of the Provider. 

4. Legally Required Disclosure. If the Recipient or its Representatives are requested or required to disclose any of the Evaluation
Material, in any such case under any applicable law, regulation or legal, judicial or administrative process or pursuant to an audit or examination by a regulator, bank examiner or self-regulatory organization (including by oral questions,
interrogatories, other requests for information or documents in legal proceedings, subpoena, civil investigative demand or other similar process), the Recipient or such Representative shall, to the extent legally permissible, provide the Provider
with prompt written notice of any such request or requirement together with copies of the material proposed to be disclosed so that the Provider may seek a protective order or other appropriate remedy and/or waive compliance with the provisions of
this Agreement; provided, that, no such notice shall be required if Recipient or its Representatives are requested or required to disclose Evaluation Material in the course of routine supervisory examinations or regulatory oversight by
banking regulatory authorities with jurisdiction over such persons. If, in the absence of a protective order or other remedy or the receipt of a waiver by the Provider, the Recipient or its Representatives are nonetheless legally required to
disclose Evaluation Material, the Recipient or its Representatives may, without liability hereunder, disclose to such requiring Person only that portion of such Evaluation Material or any such facts which the Recipient or its Representatives is
legally required to disclose, provided that the Recipient and/or its Representatives cooperate with the Provider, at the Provider’s expense, to obtain an appropriate protective order or other reliable assurance that confidential
treatment will be accorded such Evaluation Material or such facts by the Person receiving the material. 

  
 2 

 5. Return or Destruction of Evaluation Material. At any time upon the request of the
Provider for any reason, the Recipient will, and will cause its Representatives to promptly destroy or return all Evaluation Material in any way relating to the Provider or its products, services, employees or other assets or liabilities, and no
copy or extract thereof (including electronic copies) shall be retained. The Recipient shall provide to the Provider a certificate of compliance with the previous sentence signed by an executive officer of the Recipient at RigNet’s request.
Notwithstanding the foregoing, Recipient and its Representatives (i) may retain copies of the Evaluation Material in accordance with policies and procedures implemented by such persons in order to comply with applicable law, regulation,
professional standards or bona fide document retention policies; provided, that such copies are not accessed or used in violation of this Agreement and (ii) will not be required to destroy electronic versions of the Evaluation Material to the
extent such destruction is not reasonably practical; provided, that Recipient shall take reasonable steps to have such Evaluation Material destroyed and to protect the confidentiality of the Evaluation Material. Notwithstanding the return or
destruction of the Evaluation Material, the Recipient and its Representatives will continue to be bound by such Recipient’s obligations hereunder with respect to such Evaluation Material. 

6. Standstill. Unless approved in advance in writing by the Provider, the Recipient (for this purpose Recipient shall not include any
affiliates of Recipient other than those engaged in the private equity business of Kohlberg Kravis Roberts & Co. or those that have received any of the Evaluation Material or any information or encouragement from Recipient or its
Representative regarding RigNet or RigNet’s securities) agrees that neither it nor any of its Representatives acting on behalf of or in concert with the Recipient (or any of its Representatives) will, for a period commencing on the date of this
Agreement through August 26, 2016, directly or indirectly: 
 (a) make any statement or proposal to any of the board of directors of the
Provider, any of the Provider’s Representatives or any of the Provider’s stockholders regarding, or make any public announcement, proposal or offer (including any “solicitation” of “proxies” as such terms are defined or
used in Regulation 14A of the Securities Exchange Act of 1934, as amended) (x) with respect to, or otherwise solicit, seek or offer to effect (including, for the avoidance of doubt, indirectly by means of communication with the press or media)
(i) any business combination, merger, tender offer, exchange offer or similar transaction involving the Provider, (ii) any restructuring, recapitalization, liquidation or similar transaction involving the Provider, (iii) any
acquisition of any of the Provider’s loans, debt securities, equity securities or assets, or rights or options to acquire interests in any of the Provider’s loans, debt securities, equity securities or assets, (iv) any proposal to
seek representation on the board of directors of the Provider in excess of one board member or otherwise seek to control or influence the management, board of directors or policies of any of the Provider, (v) any request or proposal to waive,
terminate or amend the provisions of this Agreement or (y) that is inconsistent with the terms of this Agreement, including this Section 6(a); 

  
 3 

 (b) instigate, encourage or assist any third party (including forming a “group” with
any such third party) to do, or enter into any discussions or agreements with any third party with respect to, any of the actions set forth in clause (a) above; 

(c) take any action which would reasonably be expected to require the Provider or any of its affiliates to make a public announcement regarding
any of the actions set forth in clause (a) above; or 
 (d) acquire (or propose or agree to acquire), of record or beneficially, by
purchase or otherwise, any loans, debt securities, equity securities or assets of the Provider, or rights or options to acquire interests in any of the Provider’s loans, debt securities, equity securities or assets. 

Notwithstanding anything in the foregoing to the contrary, this Section 6 shall not apply to: 

(i) tendering or exchanging any securities of the Company in any tender offer or exchange offer initiated by any unaffiliated third party;
provided, that Recipient has not breached this Agreement in any way in connection with such tender offer or exchange offer; 
 (ii)
acquisitions of equity securities comprising of common stock of the Company or securities convertible or exchangeable into common stock of the Company so long as after giving effect to such acquisitions Digital shall own no more than 27.2% of the
fully diluted common stock of the Company; provided that any buybacks or reverse stock splits or conversion or exchange of securities after such acquisitions causing Digital to exceed 27.2% ownership of the fully diluted common stock of the
Company shall be disregarded for purposes of determining whether Recipient has breached this clause (ii); or 
 (iii) if there has been a
material breach by the Company of the registration rights agreement or director designation agreement referred to in Section 19 that has not been reasonably cured within 30 days of receipt by RigNet of written notice from the Recipient
reasonably detailing such material breach. 
 The restrictions set forth in this Section 6 shall terminate and be of no further force
and effect if the Company initiates a process to sell the Company or enters into a definitive agreement with respect to, or publicly announces that it plans to enter into, a transaction involving all or a controlling portion of the Company’s
equity securities or all or substantially all of the Company’s assets (whether by merger, consolidation, business combination, tender or exchange offer, recapitalization, restructuring, sale, equity issuance or otherwise). 

7. Compliance with Securities Laws. The Recipient acknowledges and agrees that it is aware (and that its Representatives are aware or,
upon receipt of any Evaluation Material, will be advised by the Recipient) of the restrictions imposed by the United States federal securities laws on a Person possessing material non-public information about a public company. 

  
 4 

 8. Maintaining Privileges. To the extent that any Evaluation Material includes materials
subject to the attorney-client privilege, work product doctrine or any other applicable privilege concerning pending or threatened legal proceedings or governmental investigations, none of the Provider or its Representatives is waiving, and shall
not be deemed to have waived or diminished, its attorney work-product protections, attorney-client privileges or similar protections and privileges as a result of disclosing any Evaluation Material (including Evaluation Material related to pending
or threatened litigation) to the Recipient or any of its Representatives. 
 9. No Representations or Warranties; No Obligation to
Disclose. The Recipient understands and acknowledges that neither the Provider nor its Representatives makes any representation or warranty, express or implied, as to the accuracy or completeness of the Evaluation Material furnished by or on
behalf of the Provider and shall have no liability to the Recipient, its Representatives or any other Person relating to or resulting from the use of the Evaluation Material furnished to such Recipient or its Representatives or any errors therein or
omissions therefrom. Nothing in this Agreement shall be construed as obligating the Provider to provide, or to continue to provide, any information to the Recipient, its Representatives or any other Person at any time, including before or after the
Termination Date. 
 10. Modifications and Waiver. No provision of this Agreement can be waived or amended in favor of either Party
except by written consent of the other Party, which consent shall specifically refer to such provision and explicitly make such waiver or amendment. No failure or delay by either Party in exercising any right, power or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or future exercise thereof or the exercise of any other right, power or privilege hereunder. 

11. Remedies. Each Party understands and agrees that money damages would not be a sufficient remedy for any breach of this Agreement by
the Recipient or any of its Representatives and that the Provider shall be entitled to equitable relief, including injunction and specific performance, as a remedy for any such breach or threat thereof. Such remedies shall not be deemed to be the
exclusive remedies for such breach of this Agreement, but shall be in addition to all other remedies available at law or equity to the Provider. 

12. Legal Fees. In the event of litigation relating to this Agreement, if a court of competent jurisdiction determines that the
Recipient or its Representatives has breached this Agreement, then the Recipient shall be liable and pay to the Provider the reasonable legal fees and costs incurred by the Provider in connection with such litigation, including any appeal therefrom;
provided that the Provider shall return any such payments to the Recipient to the extent a court of competent jurisdiction reverses a lower court determination that the Recipient or its Representatives has breached this Agreement. 

13. Governing Law; Consent to Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State
of Delaware. 
 14. Severability. If any term, provision, covenant or restriction contained in this Agreement is held by any court of
competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants or restrictions contained in this Agreement 

  
 5 

 
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and if a covenant or provision is determined to be unenforceable by reason of its extent, duration,
scope or otherwise, then the Parties intend and hereby request that the court or other authority making that determination shall only modify such extent, duration, scope or other provision to the extent necessary to make it enforceable and enforce
them in their modified form for all purposes of this Agreement. 
 15. Construction. The Parties have participated jointly in the
negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or
disfavoring either Party by virtue of the authorship at any of the provisions of this Agreement. 
 16. Term. This Agreement and the
provisions of this Agreement, other than the provisions of Section 6, shall terminate on the second anniversary following the date that Digital no longer is directly or indirectly the record or beneficial owner of any equity securities of
RigNet (the “Termination Date”). 
 17. Entire Agreement. This Agreement contains the entire agreement between the
Parties regarding the subject matter hereof and supersedes all prior agreements, understandings, arrangements and discussions between the Parties regarding such subject matter, including that certain Nondisclosure and Standstill Agreement among the
Company and Digital dated as of August 26, 2013, which agreement is amended, restated, and superseded by this Agreement. 
 18.
Counterparts. This Agreement may be signed in counterparts, each of which shall be deemed an original but all of which shall be deemed to constitute a single instrument. 

 

  
 6 

 IN WITNESS WHEREOF, each of the undersigned entities has caused this Agreement to be signed by
its duly authorized representatives as of the date written below. 
 Date: November 5, 2013 

 

									
	RigNet, Inc.	 		 	Digital Oilfield Investments LP
			
	 ADDRESS FOR NOTICE:
 1880 S. Dairy
Ashford, Suite 300
 Houston, Texas 77077-4760
 Attention:
General Counsel
	 		 	 ADDRESS FOR NOTICE:
 c/o Kohlberg
Kravis Roberts & Co. L.P.
 9 West 57th Street, Suite 4200

New York, New York 10019
 Attention: David Sorkin, Esq.

Fax: (212) 750-0003

					
	By:	 	/s/ Mark B. Slaughter	 		 	By:	 	Digital Oilfield Investments GP
		 	Name: Mark B. Slaughter	 		 		 	Limited, its general partner
		 	Title: CEO & President	 		 		 	
					
		 		 		 	By:	 	/s/ Mattia Caprioli
		 		 		 		 	Name: Mattia Caprioli
		 		 		 		 	Title: Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00223-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00223-of-00352.parquet"}]]